Bavarian Nordic Announces that the Oxford Vaccines Group has Initiated a Phase 2 Study of the Ebola Prime-Boost Vaccine Regimen Combining MVA-BN(r) Filo and Janssen's AdVac(r) Technology
July 15, 2015 02:10 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, July 15, 2015 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Oxford Vaccines Group has initiated a Phase 2 clinical study of the Ebola...
Bavarian Nordic Announces that the Oxford Vaccines Group has Initiated a Phase 2 Study of the Ebola Prime-Boost Vaccine Regimen Combining MVA-BN® Filo and Janssen's AdVac® Technology
July 15, 2015 02:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark, July 15, 2015 - Bavarian...
Bavarian Nordic offentliggør at Oxford Vaccines Group har påbegyndt fase 2 studie med prime-boost forsøgsvaccinen mod ebola der kombinerer MVA-BN® Filo og Janssens AdVac® teknologi
July 15, 2015 02:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark - 15. juli 2015 - Bavarian...
Bavarian Nordic Receives Order for IMVAMUNE® Smallpox Vaccine from the U.S. Government Valued at USD 133 Million
July 07, 2015 01:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Bulk supply order will help maintain current...
Bavarian Nordic indgår kontrakt med den amerikanske regering om produktion af IMVAMUNE® koppevaccine på USD 133 mio.
July 07, 2015 01:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Bulkproduktionsordre bidrager til...
Den amerikanske regering udnytter optioner i kontrakt med Bavarian Nordic om udvikling af en filovirus vaccine
June 30, 2015 01:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KØBENHAVN, Danmark - 30. juni 2015 - Bavarian...
Bavarian Nordic Announces Option Exercise by U.S. Government for Development of Filovirus Vaccine
June 30, 2015 01:30 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
COPENHAGEN, Denmark - June 30, 2015 - Bavarian...
Total number of voting rights and share capital in Bavarian Nordic A/S
May 31, 2015 11:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark, May 31, 2015 - Bavarian...
Indberetning af aktiekapital og stemmerettigheder for Bavarian Nordic A/S
May 31, 2015 11:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark - 31. maj 2015 - Bavarian...
Bavarian Nordic to Present at Jefferies 2015 Global Healthcare Conference in New York
May 28, 2015 12:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark - May 28, 2015 - Bavarian...